Chatham Capital Group’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.47M Buy
46,545
+2,710
+6% +$278K 0.57% 53
2026
Q1
$4.79M Sell
43,835
-4,210
-9% -$401K 0.69% 42
2025
Q4
$3.9M Buy
48,045
+600
+1% +$51.7K 0.55% 59
2025
Q3
$4.15M Sell
47,445
-2,539
-5% -$227K 0.6% 51
2025
Q2
$4.15M Sell
49,984
-270
-0.5% -$22.6K 0.63% 47
2025
Q1
$4.22M Buy
50,254
+1,765
+4% +$164K 0.7% 43
2024
Q4
$4.47M Sell
48,489
-1,570
-3% -$151K 0.73% 38
2024
Q3
$4.65M Buy
50,059
+105
+0.2% +$9.1K 0.76% 39
2024
Q2
$4.11M Buy
49,954
+725
+1% +$53.3K 0.72% 43
2024
Q1
$3.27M Buy
49,229
+8,770
+22% +$541K 0.6% 54
2023
Q4
$2.3M Sell
40,459
-394
-1% -$20.6K 0.47% 64
2023
Q3
$2.23M Sell
40,853
-206
-0.5% -$12.2K 0.5% 64
2023
Q2
$2.76M Buy
41,059
+2,465
+6% +$150K 0.58% 54
2023
Q1
$1.99M Buy
38,594
+26
+0.1% +$1.26K 0.44% 76
2022
Q4
$1.77M Hold
38,568
0.42% 78
2022
Q3
$1.96M Hold
38,568
0.48% 68
2022
Q2
$1.76M Buy
38,568
+55
+0.1% +$2.46K 0.4% 75
2022
Q1
$1.79M Buy
38,513
+566
+1% +$25.3K 0.35% 80
2021
Q4
$1.91M Buy
37,947
+60
+0.2% +$3.1K 0.34% 76
2021
Q3
$2.01M Sell
37,887
-436
-1% -$24.6K 0.39% 70
2021
Q2
$2.34M Buy
38,323
+4
+0% +$212 0.45% 66
2021
Q1
$1.87M Buy
38,319
+1,142
+3% +$53.5K 0.39% 72
2020
Q4
$1.51M Sell
37,177
-250
-0.7% -$8.94K 0.34% 80
2020
Q3
$1.22M Sell
37,427
-178
-0.5% -$5.34K 0.3% 80
2020
Q2
$993K Buy
37,605
+88
+0.2% +$2.3K 0.26% 88
2020
Q1
$935K Buy
37,517
+13,023
+53% +$402K 0.28% 85
2019
Q4
$881K Sell
24,494
-506
-2% -$17.5K 0.22% 101
2019
Q3
$854K Sell
25,000
-230
-0.9% -$7.35K 0.22% 103
2019
Q2
$706K Sell
25,230
-414
-2% -$11.5K 0.18% 112
2019
Q1
$795K Buy
25,644
+184
+0.7% +$4.91K 0.2% 102
2018
Q4
$602K Buy
+25,460
New +$695K 0.17% 105

Other funds holding LMAT